AllSight
Companies · CELC · Services-Medical Laboratories

Celcuity Inc. (CELC)

Celcuity Inc. (CELC) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Celcuity Inc. (CELC) stock — financials & valuation

Key numbers for Celcuity Inc. (CELC): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 49/100 — a percentile rank of Celcuity Inc.’s fundamentals against Services peers, weakest on growth. A quality ranking, not a price prediction.

Market cap$3.9B
EV / EBITDA-21.4×
Return on equity1772.0%
ROIC-37.4%
Debt / equity-58.9×
Dividend yield0.0%

Independent of the events above — derived from Celcuity Inc.’s own financial statements and shown as context, never as advice.

Sep 30, 2026U.S. launch
Celcuity commercial launch begins for REVTORPYK, but sales proof comes later
Aug 26, 2026sNDA submitted
Celcuity submits REVTORPYK sNDA, opening PIK3CA-mutant label expansion
Aug 13, 2026Beat
The launch is real—but the bigger upside is hiding in mutant breast cancer
Related companies in Services-Medical Laboratories
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact